QRX-004

N/A

Report date: 2022/01/14 15:29:29
NME

Base Information

Drug NameQRX-004
Drug Alias NameQRX-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCollagen modulatorsSerine protease inhibitors
TargetsCollagenSerine protease
Therapy Area/IndicationsEpidermolysis Bullosa Dystrophica
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuoin Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQuoin Pharmaceuticals LtdHongkong WinHealth Pharma Group Co Ltd
Inactive CompaniesN/A
Active IndicationsEpidermolysis Bullosa Dystrophica
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A